Vericel Corporation (VCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VCEL | PVLA | ANIP | ||
| Company | Vericel Corporation | Palvella Therapeutics Inc | ANI Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 34.61 | 126.64 | 79.11 | ||
| High | 35.86 | 131.66 | 81.20 | ||
| Low | 34.35 | 125.40 | 78.79 | ||
| Latest | 35.68 | 130.01 | 80.92 | ||
| Change | +1.91 | +5.83 | +2.85 | ||
| % Change | +5.66% | +4.69% | +3.65% | ||
| Volume | 441,100 | 303,700 | 552,900 | ||
| 20-Day Average Volume | 729,795 | 271,205 | 344,350 | ||
| Previous Close | 33.77 | 124.18 | 78.07 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 33.05 | 121.85 | 76.50 | ||
| 20-Day Raw Stochastic | 97.40% | 84.24% | 87.76% | ||
| 20-Day Relative Strength | 55.35 | 56.86 | 57.75 | ||
| Weighted Alpha | -8.98 | +226.44 | +7.85 | ||
| Today's Opinion | 24% Sell | 100% Buy | 24% Sell | ||
| Previous Opinion | 72% Sell | 100% Buy | 56% Sell | ||
| Last Month's Opinion | 72% Sell | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.88% since 04/10/26 | +2.27% since 04/10/26 | +3.27% since 04/10/26 | ||
| Low | 32.99 on 04/13/26 | 121.47 on 04/16/26 | 75.88 on 04/15/26 | ||
| High | 35.86 on 04/17/26 | 133.33 on 04/15/26 | 81.20 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +9.78% since 03/17/26 | +7.62% since 03/17/26 | +8.94% since 03/17/26 | ||
| Low | 28.95 on 03/27/26 | 108.63 on 03/30/26 | 72.20 on 03/18/26 | ||
| High | 35.86 on 04/17/26 | 134.01 on 04/09/26 | 82.08 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | -4.60% since 01/16/26 | +30.36% since 01/16/26 | -4.61% since 01/16/26 | ||
| Low | 28.95 on 03/27/26 | 72.22 on 01/30/26 | 70.15 on 03/13/26 | ||
| High | 39.48 on 01/23/26 | 151.18 on 02/26/26 | 86.97 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +1.02% since 10/17/25 | +77.73% since 10/17/25 | -14.63% since 10/17/25 | ||
| Low | 28.95 on 03/27/26 | 68.96 on 10/28/25 | 70.15 on 03/13/26 | ||
| High | 43.00 on 11/06/25 | 151.18 on 02/26/26 | 97.00 on 10/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,817,254 | 1,860,963 | 1,813,740 | ||
| Shares Outstanding, K | 50,932 | 14,314 | 22,414 | ||
| Annual Sales | 276,260,000 | 0 | 883,370,000 | ||
| Annual Net Income | 16,520,000 | -41,720,000 | 78,340,000 | ||
| Last Quarter Sales | 92,920,000 | 0 | 247,060,000 | ||
| Last Quarter Net Income | 23,240,000 | -12,710,000 | 27,490,000 | ||
| 60-Month Beta | 1.20 | -0.21 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.45 on 02/26/26 | -1.08 on 03/31/26 | 2.33 on 02/27/26 | ||
| Latest Earnings Date | 05/14/26 | 05/21/26 | 05/08/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 108.94 | 0.00 | 12.26 | ||